secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immix Biopharma, Inc. (IMMX)
CIK:        0001873835
Form:       8-K
Filed at:   2023-06-08T23:59:59+00:00
Accession:  0001493152-23-020507
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Immix Biopharma shareholders elect 7 directors, ratify auditor, approve equity plan
--------------------------------------------------------------------------------

- All seven director nominees elected: Rachman, Morris, Hsu, Marquet, Adams, Ng, Buchan.
- Ratification of KMJ Corbin as auditor approved: 9,497,865 for, 36,813 against, 7,792 abstain.
- Amended 2021 Omnibus Equity Incentive Plan approved: 7,315,768 for, 295,959 against, 10,792 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1873835/000149315223020507/0001493152-23-020507-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1873835/000149315223020507/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-020507

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer